Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography
- PMID: 21861971
- PMCID: PMC3223264
- DOI: 10.1016/j.ajo.2011.05.028
Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography
Abstract
Purpose: To identify a clinically meaningful threshold for change in retinal thickness measured by optical coherence tomography for patients with uveitic macular edema using correlation with change in visual acuity.
Design: Cross-sectional and longitudinal study.
Methods: One hundred twenty-eight eyes (101 individuals) with macular edema enrolled in the Multicenter Uveitis Steroid Treatment (MUST) trial. At enrollment and after 6 months of follow-up, retinal thickness was measured at the central subfield with time-domain optical coherence tomography and visual acuity was measured with logarithmic (Early Treatment Diabetic Retinopathy Study) visual acuity charts. Participants were classified as having macular edema if the retinal thickness was 260 μm or more.
Results: A threshold for change in retinal center subfield thickness of 20% balanced the percentage of false positives and false negatives for predicting more than a 10-letter change in visual acuity with a sensitivity of 77% and a specificity of 75%. The results were similar for more than 5-letter changes and for 15-letter or more changes. Those with a 20% or more reduction in retinal thickness had a mean 11.0-letter improvement (95% confidence interval, 7.7 to 14.3) as compared with a -0.4-letter change (95% confidence interval, -4.1 to 3.3) in visual acuity for those without a 20% reduction (P < .01).
Conclusions: In addition to being above the level of measurement uncertainty, a 20% change in retinal thickness in patients with macular edema seems to be optimal for clinically important changes in visual acuity and may be considered as an outcome for clinical trials of treatments for uveitic macular edema.
Trial registration: ClinicalTrials.gov NCT00132691.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures


Similar articles
-
Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results.Ophthalmology. 2021 May;128(5):719-728. doi: 10.1016/j.ophtha.2020.08.035. Epub 2020 Sep 10. Ophthalmology. 2021. PMID: 32918964 Free PMC article. Clinical Trial.
-
Early treatment response of fluocinolone (retisert) implantation in patients with uveitic macular edema: an optical coherence tomography study.Retina. 2013 Apr;33(4):873-7. doi: 10.1097/IAE.0b013e31826d36dd. Retina. 2013. PMID: 23407350
-
Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.Ophthalmology. 2015 Nov;122(11):2351-9. doi: 10.1016/j.ophtha.2015.07.036. Epub 2015 Sep 7. Ophthalmology. 2015. PMID: 26359188 Free PMC article. Clinical Trial.
-
Intravitreal steroids for macular edema in diabetes.Cochrane Database Syst Rev. 2020 Nov 17;11(11):CD005656. doi: 10.1002/14651858.CD005656.pub3. Cochrane Database Syst Rev. 2020. PMID: 33206392 Free PMC article.
-
Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology.Ophthalmology. 2024 Sep;131(9):1107-1120. doi: 10.1016/j.ophtha.2024.02.019. Epub 2024 Apr 20. Ophthalmology. 2024. PMID: 38647511 Review.
Cited by
-
Advances and potential new developments in imaging techniques for posterior uveitis. Part 1: noninvasive imaging methods.Eye (Lond). 2021 Jan;35(1):33-51. doi: 10.1038/s41433-020-1063-1. Epub 2020 Jul 16. Eye (Lond). 2021. PMID: 32678354 Free PMC article. Review.
-
Development of an activity disease score in patients with uveitis (UVEDAI).Rheumatol Int. 2017 Apr;37(4):647-656. doi: 10.1007/s00296-016-3593-1. Epub 2016 Nov 4. Rheumatol Int. 2017. PMID: 27815703 Free PMC article.
-
Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema.Am J Ophthalmol. 2022 May;237:310-324. doi: 10.1016/j.ajo.2021.10.024. Epub 2021 Nov 3. Am J Ophthalmol. 2022. PMID: 34740628 Free PMC article.
-
Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis.Orphanet J Rare Dis. 2015 Aug 19;10:97. doi: 10.1186/s13023-015-0318-6. Orphanet J Rare Dis. 2015. PMID: 26286265 Free PMC article.
-
Microcystic Inner Nuclear Layer Changes and Retinal Nerve Fiber Layer Defects in Eyes with Glaucoma.PLoS One. 2015 Jun 12;10(6):e0130175. doi: 10.1371/journal.pone.0130175. eCollection 2015. PLoS One. 2015. PMID: 26066021 Free PMC article.
References
-
- Lardenoye CW, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113(8):1446–1449. - PubMed
-
- Nussenblatt RB, Kaufman SC, Palestine AG, Davis MD, Ferris FL., 3rd Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology. 1987;94(9):1134–1139. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical